Bursa Announcements
Stock Name / Code :
DPHARMA ( 7148 )
Year :
2026
2025
2024
2023
2022
Archives
Select Date Range :
Categories :
Category
Additional Listing Announcement
Annual Audited Accounts
Annual Reports
Change of Corporate Information
Changes in Shareholdings
Circulars/Notice to Shareholders
Dealings in Listed Securities (Chapter 14 of Listing Requirements)
Delisting of Securities
Disclosure On Quarterly Production
Entitlements
Expiry / Maturity / Termination of Securities
Financial Results
General Announcement
General Meetings
Important Relevant Dates for Renounceable Rights
Investor Alert
IPO Announcement/LEAP Market Announcement
Listing Circulars
Listing Information and Profile
Prospectus
Reply to Query
Shares Buy Back
Special Announcements
Take-over Offer
Transfer of Listing
Unusual Market Activity
Filter
Reset
Monday - 24 Nov 2025
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
Friday - 21 Nov 2025
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Thursday - 20 Nov 2025
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Wednesday - 19 Nov 2025
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Tuesday - 18 Nov 2025
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Thursday - 13 Nov 2025
Change in Audit Committee - DR HASNITA BINTI HASHIM
Change in Audit Committee - DATO' ADNAN HISHAM BIN PAWANTEH
Change in Boardroom - DATO' EISAH BINTI A. RAHMAN
Change in Boardroom - DATUK WIRA ARHAM BIN ABDUL RAHMAN
Change in Risk Committee - DATO' EISAH BINTI A. RAHMAN
Change in Nomination and Remuneration Committee
Change in Risk Committee - ENCIK MOHAMAD IDROS BIN MOSIN
Change in Nomination and Remuneration Committee
OTHERS
CHANGE IN THE COMPOSITION OF THE BOARD COMMITTEES OF DUOPHARMA BIOTECH BERHAD
OTHERS
Duopharma Biotech achieves strong profitability in Q3 FY2025
«
1
2
3
4
5
6
7
8
9
10
»